J.W. Childs Associates is providing growth funding to A4, an Ann Arbor, Michigan-based provider of anesthesia and pain management services. As part of the transaction, J.W. Childs will merge A4 with portfolio company Siromed, a provider of anesthesiology physician services to hospitals, ASCs and other healthcare facilities. No financial terms were disclosed. Houlihan Lokey and Sheppard Mullin advised A4 on the deal while McDermott Will & Emery advised J.W. Childs and Siromed.
ANN ARBOR, Mich.–(BUSINESS WIRE)–Anesthesia Associates of Ann Arbor and Midwest Anesthesia Consultants (collectively “A4”), the leading independent provider of anesthesia and pain management services in the Midwest, has partnered with J.W. Childs Associates (“J.W. Childs”), a leading Boston based middle-market private equity firm. As part of the transaction, J.W. Childs will provide growth equity capital to support A4’s continued expansion and A4 will combine with J.W. Childs’ existing portfolio company Siromed.
Founded in 1968 and headquartered in Ann Arbor, Michigan, A4 is the largest provider of anesthesia and pain management services in the State of Michigan. A4 attributes its ongoing growth and success to a keen focus on delivering top quality, cutting-edge health care to patients, while providing a high degree of engagement and customer service to its health system partners. With over 110 physician anesthesiologists, A4 currently provides services to 11 hospitals, six ambulatory surgery centers (ASCs) and four chronic pain management clinics.
J.W. Childs is a Boston-based private equity firm focused on investing in middle-market growth companies. Since inception in 1995, J.W. Childs has invested $3.6 billion of equity capital in more than 49 companies across the healthcare, consumer, and specialty retail/ecommerce industries. The firm’s success has been built on its industry focus and the extensive operating expertise of its partners.
Siromed currently is a provider of anesthesiology physician services to hospitals, ASCs and other healthcare facilities, founded in South Florida. Siromed was founded in 2017 to pursue partnerships with a broad array of physician services practices throughout North America, especially those seeking capital to support the development of their practices while maintaining clinical autonomy.
“J.W. Childs and Siromed bring their expertise at managing practices on a large scale while keeping quality and compliance in the forefront of all they do. Their access to financial resources will provide us with the tools to continue to meet the demands of our hospital partners and patients now and into the future,” said Dr. Traci Coffman, President of A4.
Dr. Lewis Gold and Dr. Mitchell Eisenberg, former President and CEO of Sheridan Healthcare, respectively, who also serve on the Board of Directors of Siromed commented “We are very excited to have the A4 organization join the Siromed platform as we continue to develop a best in class physician practice management organization.”
Adam Suttin, Managing Partner of J.W. Childs commented “We were very impressed with A4’s clinical quality and leadership and look forward to assisting A4 in their next phase of growth. Our mission in founding Siromed was to allow leading groups like A4 to maintain clinical and operational autonomy while assisting them with the resources they need to grow.”
Houlihan Lokey and Sheppard Mullin advised A4 on the transaction. McDermott Will & Emery advised J.W. Childs and Siromed.